Cargando…

Phage therapy in allergic disorders?

Allergic disorders pose a growing challenge to medicine and our society. Therefore, novel approaches to prevention and therapy are needed. Recent progress in studies on bacterial viruses (phages) has provided new data indicating that they have significant immunomodulating activities. We show how tho...

Descripción completa

Detalles Bibliográficos
Autores principales: Górski, Andrzej, Jończyk-Matysiak, Ewa, Łusiak-Szelachowska, Marzanna, Międzybrodzki, Ryszard, Weber-Dąbrowska, Beata, Borysowski, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882018/
https://www.ncbi.nlm.nih.gov/pubmed/29359577
http://dx.doi.org/10.1177/1535370218755658
_version_ 1783311396964925440
author Górski, Andrzej
Jończyk-Matysiak, Ewa
Łusiak-Szelachowska, Marzanna
Międzybrodzki, Ryszard
Weber-Dąbrowska, Beata
Borysowski, Jan
author_facet Górski, Andrzej
Jończyk-Matysiak, Ewa
Łusiak-Szelachowska, Marzanna
Międzybrodzki, Ryszard
Weber-Dąbrowska, Beata
Borysowski, Jan
author_sort Górski, Andrzej
collection PubMed
description Allergic disorders pose a growing challenge to medicine and our society. Therefore, novel approaches to prevention and therapy are needed. Recent progress in studies on bacterial viruses (phages) has provided new data indicating that they have significant immunomodulating activities. We show how those activities could be translated into beneficial effects in allergic disorders and present initial clinical data that support this hope. IMPACT STATEMENT: Allergic disorders pose a growing challenge to medicine and our society, so new approaches to prevention and therapy are urgently needed. Our article summarizes progress that has been recently made and presents a shift in our understanding of the immunobiological significance of bacterial viruses (phages). Currently, phages may be considered not only as mere “bacteria eaters” but also as regulators of immunity. The new understanding of phages as important factors in maintenance of immune homeostasis opens completely new perspectives for their use in controlling aberrant immune responses. It is likely that this new knowledge could be translated into novel means of immunotherapy of allergic disorders.
format Online
Article
Text
id pubmed-5882018
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-58820182019-03-01 Phage therapy in allergic disorders? Górski, Andrzej Jończyk-Matysiak, Ewa Łusiak-Szelachowska, Marzanna Międzybrodzki, Ryszard Weber-Dąbrowska, Beata Borysowski, Jan Exp Biol Med (Maywood) Immunology/Microbiology/Virology Allergic disorders pose a growing challenge to medicine and our society. Therefore, novel approaches to prevention and therapy are needed. Recent progress in studies on bacterial viruses (phages) has provided new data indicating that they have significant immunomodulating activities. We show how those activities could be translated into beneficial effects in allergic disorders and present initial clinical data that support this hope. IMPACT STATEMENT: Allergic disorders pose a growing challenge to medicine and our society, so new approaches to prevention and therapy are urgently needed. Our article summarizes progress that has been recently made and presents a shift in our understanding of the immunobiological significance of bacterial viruses (phages). Currently, phages may be considered not only as mere “bacteria eaters” but also as regulators of immunity. The new understanding of phages as important factors in maintenance of immune homeostasis opens completely new perspectives for their use in controlling aberrant immune responses. It is likely that this new knowledge could be translated into novel means of immunotherapy of allergic disorders. SAGE Publications 2018-01-23 2018-03 /pmc/articles/PMC5882018/ /pubmed/29359577 http://dx.doi.org/10.1177/1535370218755658 Text en © 2018 by the Society for Experimental Biology and Medicine http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Immunology/Microbiology/Virology
Górski, Andrzej
Jończyk-Matysiak, Ewa
Łusiak-Szelachowska, Marzanna
Międzybrodzki, Ryszard
Weber-Dąbrowska, Beata
Borysowski, Jan
Phage therapy in allergic disorders?
title Phage therapy in allergic disorders?
title_full Phage therapy in allergic disorders?
title_fullStr Phage therapy in allergic disorders?
title_full_unstemmed Phage therapy in allergic disorders?
title_short Phage therapy in allergic disorders?
title_sort phage therapy in allergic disorders?
topic Immunology/Microbiology/Virology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882018/
https://www.ncbi.nlm.nih.gov/pubmed/29359577
http://dx.doi.org/10.1177/1535370218755658
work_keys_str_mv AT gorskiandrzej phagetherapyinallergicdisorders
AT jonczykmatysiakewa phagetherapyinallergicdisorders
AT łusiakszelachowskamarzanna phagetherapyinallergicdisorders
AT miedzybrodzkiryszard phagetherapyinallergicdisorders
AT weberdabrowskabeata phagetherapyinallergicdisorders
AT borysowskijan phagetherapyinallergicdisorders